Guidelines for ATC classification and DDD assignment - WHOCC

More documents

Recommendations

Info

B05XX Other i.v. solution additives This group comprises all i.v. additives, which cannot be classified in the preceding groups. B05Z HEMODIALYTICS AND HEMOFILTRATES B05ZA Hemodialytics, concentrates B05ZB Hemofiltrates B06 OTHER HEMATOLOGICAL AGENTS No DDDs are established in this group. B06A OTHER HEMATOLOGICAL AGENTS This group includes preparations for local and systemic use, and also some preparations used for dissolving clots in catheters, hemodialysis clots etc. See also: B06AA Enzymes V07A - All other non-therapeutic products B01AB - Heparin group This group comprises enzymes with fibrinolytic properties. Enzymes with other well defined therapeutic use should be classified in the respective groups, see e.g.: A09A - Digestives, incl. enzymes B01AD - Enzymes D03BA - Proteolytic enzymes S01KX - Other surgical aids B06AB Other hem products 93
Page 1 and 2:
2011 WHO Collaborating Centre for D
Page 3 and 4:
ISSN 1726-4898 ISBN 978-82-8082-438
Page 5 and 6:
Previous editions: 1990: Guidelines
Page 7 and 8:
Staff of the Centre Christian Berg,
Page 9 and 10:
8 D. Principles for reviewing and c
Page 11 and 12:
I. INTRODUCTION A. History of the A
Page 13 and 14:
- To organize training courses in t
Page 15 and 16:
It is open to anyone with a legitim
Page 17 and 18:
B. Inclusion and exclusion criteria
Page 19 and 20:
If a new substance fits in both a c
Page 21 and 22:
Example: N02BA71 - acetylsalicylic
Page 23 and 24:
achieved. The harmonisation process
Page 25 and 26:
- For some groups of medicinal prod
Page 27 and 28:
For all combination products where
Page 29 and 30:
- Liquid preparations for inhalatio
Page 31 and 32:
Further reviews of DDDs After the f
Page 33 and 34:
linked to each medicinal product on
Page 35 and 36:
Use of the ATC/DDD system allows st
Page 37 and 38:
The WHO Collaborating Centre for In
Page 39 and 40:
It should be emphasised that assign
Page 41 and 42:
- If no objections are received, th
Page 43 and 44: In order to include proposals for A
Page 45 and 46: considered as a guideline since the
Page 47 and 48: List of DDDs for combined products
Page 49 and 50: ATC SYSTEM MAIN GROUPS The main gro
Page 51 and 52: A08 ANTIOBESITY PREPARATIONS, EXCL.
Page 53 and 54: A01AC Corticosteroids for local ora
Page 55 and 56: A02AF Antacids with antiflatulents
Page 57 and 58: 56 combination will, together with
Page 59 and 60: 58 The classification at the 5th le
Page 61 and 62: A03EA Antispasmodics, psycholeptics
Page 63 and 64: A06 LAXATIVES A06A LAXATIVES 62 Lax
Page 65 and 66: A06AG Enemas 64 All enemas and laxa
Page 67 and 68: A07C ELECTROLYTES WITH CARBOHYDRATE
Page 69 and 70: A08 ANTIOBESITY PREPARATIONS, EXCL.
Page 71 and 72: A10B BLOOD GLUCOSE LOWERING DRUGS,
Page 73 and 74: 72 In A11AA04 only trace elements a
Page 75 and 76: 74 The DDDs are based on prophylaxi
Page 77 and 78: 76 classified in this group. Even c
Page 79 and 80: 78 Tonics are classified in A13. Th
Page 81 and 82: A12CC Magnesium A12CD Fluoride A12C
Page 83 and 84: A16 OTHER ALIMENTARY TRACT AND META
Page 85 and 86: B BLOOD AND BLOOD FORMING ORGANS B0
Page 87 and 88: B02 ANTIHEMORRHAGICS B02A ANTIFIBRI
Page 89 and 90: B03AA Iron bivalent, oral preparati
Page 91 and 92: 90 The DDDs are based on maintenanc
Page 93: B05C IRRIGATING SOLUTIONS 92 In thi
Page 97 and 98: C08 CALCIUM CHANNEL BLOCKERS C Sele
Page 99 and 100: 98 Adenosine, which is also used as
Page 101 and 102: 100 Combinations with cardiac glyco
Page 103 and 104: C02 ANTIHYPERTENSIVES 102 See also
Page 105 and 106: C02CA Alpha-adrenoreceptor antagoni
Page 107 and 108: 106 Diuretics in combination with a
Page 109 and 110: C03A LOW-CEILING DIURETICS, THIAZID
Page 111 and 112: C03E DIURETICS AND POTASSIUM-SPARIN
Page 113 and 114: C05AA Corticosteroids 112 All antih
Page 115 and 116: 114 The DDDs are based on the treat
Page 117 and 118: C07E BETA BLOCKING AGENTS AND VASOD
Page 119 and 120: C08E NON-SELECTIVE CALCIUM CHANNEL
Page 121 and 122: C10AA HMG CoA reductase inhibitors
Page 124 and 125: D DERMATOLOGICALS D01 ANTIFUNGALS F
Page 126 and 127: D DERMATOLOGICALS Most of the drugs
Page 128 and 129: Some similar products are classifie
Page 130 and 131: Topical products containing glycery
Page 132 and 133: D05BA Psoralens for systemic use Th
Page 134 and 135: Combinations of corticosteroids and
Page 136 and 137: D07XC Corticosteroids, potent, othe
Page 138 and 139: D09 MEDICATED DRESSINGS D09A MEDICA
Page 140 and 141: D10BX Other anti-acne preparations
Page 142 and 143: G GENITO URINARY SYSTEM AND SEX HOR
Page 144 and 145:
G01AF Imidazole derivatives Imidazo
Page 146 and 147:
G02B CONTRACEPTIVES FOR TOPICAL USE
Page 148 and 149:
Intravaginal and intrauterine devic
Page 150 and 151:
Hormonal contraceptives, see G03A.
Page 152 and 153:
The DDDs are based on the treatment
Page 154 and 155:
The DDDs are based on the treatment
Page 156:
The DDD of phenazopyridine is based
Page 159 and 160:
H SYSTEMIC HORMONAL PREPARATIONS, E
Page 161 and 162:
160 The DDD of nafarelin is based o
Page 163 and 164:
H03 THYROID THERAPY H03A THYROID PR
Page 165 and 166:
H05BX Other anti-parathyroid agents
Page 167 and 168:
J ANTIINFECTIVES FOR SYSTEMIC USE 1
Page 169 and 170:
J01C BETA-LACTAM ANTIBACTERIALS, PE
Page 171 and 172:
170 particularly methicillin suscep
Page 173 and 174:
J01FF Lincosamides 172 Orally and p
Page 175 and 176:
J01XB Polymyxins 174 This group com
Page 177 and 178:
J02AC Triazole derivatives 176 All
Page 179 and 180:
J05AC Cyclic amines 178 Amantadine
Page 181 and 182:
180 is mainly related to the manufa
Page 183 and 184:
J07AX Other bacterial vaccines 182
Page 186 and 187:
L ANTINEOPLASTIC AND IMMUNOMODULATI
Page 188 and 189:
L01B ANTIMETABOLITES L01BA Folic ac
Page 190 and 191:
L02A HORMONES AND RELATED AGENTS An
Page 192:
The DDDs are mainly based on prophy
Page 195 and 196:
M MUSCULO-SKELETAL SYSTEM M01 ANTII
Page 197 and 198:
196 The DDD for glucosamine refers
Page 199 and 200:
198 Combined preparations containin
Page 201 and 202:
M03C MUSCLE RELAXANTS, DIRECTLY ACT
Page 203 and 204:
M05BX Other drugs affecting bone st
Page 205 and 206:
N NERVOUS SYSTEM N01 ANESTHETICS 20
Page 207 and 208:
N01BC Esters of benzoic acid N01BX
Page 209 and 210:
208 The DDDs are based on approved
Page 211 and 212:
210 This means that a product conta
Page 213 and 214:
212 Tolfenamic acid, see M01AG - Fe
Page 215 and 216:
214 Benzodiazepines mainly used as
Page 217 and 218:
N05A ANTIPSYCHOTICS 216 This group
Page 219 and 220:
218 The parenteral DDD for chlordia
Page 221 and 222:
N05CM Other hypnotics and sedatives
Page 223 and 224:
N06C PSYCHOLEPTICS AND PSYCHOANALEP
Page 225 and 226:
N07CA Antivertigo preparations 224
Page 227 and 228:
P ANTIPARASITIC PRODUCTS, INSECTICI
Page 229 and 230:
P01BC Methanolquinolines 228 Combin
Page 231 and 232:
P02 ANTHELMINTICS 230 The anthelmin
Page 233 and 234:
P03A ECTOPARASITICIDES, INCL. SCABI
Page 235 and 236:
R RESPIRATORY SYSTEM 234 Inhaled an
Page 237 and 238:
R01B NASAL DECONGESTANTS FOR SYSTEM
Page 239 and 240:
238 The DDDs for inhalation aerosol
Page 241 and 242:
R03C ADRENERGICS FOR SYSTEMIC USE 2
Page 243 and 244:
242 Fixed DDDs are assigned for com
Page 245 and 246:
R05X OTHER COLD COMBINATION PREPARA
Page 247 and 248:
R07AA Lung surfactants 246 This gro
Page 249 and 250:
S SENSORY ORGANS 248 A formulation
Page 251 and 252:
S01CB Corticosteroids/antiinfective
Page 253 and 254:
S01H LOCAL ANESTHETICS 252 This gro
Page 255 and 256:
S02A ANTIINFECTIVES 254 This group
Page 257 and 258:
S03B CORTICOSTEROIDS 256 This group
Page 259 and 260:
V10 THERAPEUTIC RADIOPHARMACEUTICAL
Page 261 and 262:
260 Silibinin, which is also used i
Page 263 and 264:
V04 DIAGNOSTIC AGENTS V04B URINE TE
Page 265 and 266:
V06DX Other combinations of nutrien
Page 267 and 268:
V08B X-RAY CONTRAST MEDIA, NON-IODI
Page 269 and 270:
268 V09E - Respiratory system. Tech
Page 271 and 272:
V09H INFLAMMATION AND INFECTION DET
Page 273 and 274:
272 Iobenguane ( 131 I) in low dose
Page 275 and 276:
DDDs per 100 bed days Applied when
Page 278:
ANNEX I
Page 281 and 282:
Status concerning Marketing Authori
Page 284 and 285:
ORDER FORM ATC/DDD PUBLICATIONS 201
Page 286:
WHO Collaborating Centre for Drug S
show all

Guidelines for ATC classification and DDD assignment - WHOCC

Create successful ePaper yourself

Delete template?

Save as template?